Boswellia serrata, also known as Indian frankincense, has been used in traditional Ayurvedic medicine for centuries to treat inflammatory conditions. The gum resin of this tree contains boswellic acids, a group of pentacyclic triterpenic acids that have demonstrated significant anti-inflammatory and analgesic properties. Modern research has validated the traditional use of Boswellia serrata, making standardized Boswellia Serrata Extract a valuable ingredient in the nutraceutical and pharmaceutical industries.
Boswellia Serrata Extract is produced from the gum resin of Boswellia serrata using alcohol extraction. The extract appears as a yellow-white to light yellow fine powder and is available in multiple standardized grades, including 65%, 70%, and 80% Boswellic Acid content. All products are tested by HPLC, and Greensky Bio maintains rigorous quality control standards with PAHs below 50ppb and BAP below 10ppb.
The primary active compounds in Boswellia Serrata Extract are boswellic acids, particularly acetyl-11-keto-beta-boswellic acid (AKBA), which is the most potent inhibitor of 5-lipoxygenase (5-LOX). By inhibiting 5-LOX, boswellic acids block the conversion of arachidonic acid to leukotrienes, which are potent pro-inflammatory mediators involved in asthma, allergic reactions, and inflammatory conditions.
Unlike non-steroidal anti-inflammatory drugs that inhibit cyclooxygenase enzymes and can cause gastrointestinal side effects, boswellic acids target the 5-LOX pathway without significant effects on the gastric mucosa. This selective mechanism provides anti-inflammatory benefits with a favorable safety profile, making Boswellia Serrata Extract particularly suitable for long-term use in chronic inflammatory conditions.
Clinical research has demonstrated the efficacy of Boswellia Serrata Extract in reducing pain and improving joint function in osteoarthritis patients. Studies have shown significant reductions in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, indicating improvements in pain, stiffness, and physical function. The extract has also shown promise in managing inflammatory bowel conditions, reducing markers of inflammation and improving clinical symptoms.
Beyond its anti-inflammatory properties, boswellic acids have demonstrated anti-proliferative effects in various cancer cell lines, inducing apoptosis and inhibiting tumor growth. They also exhibit immunomodulatory properties, affecting both innate and adaptive immune responses.
Boswellia Serrata Extract is primarily used in the dietary supplement industry for joint health, inflammation management, and respiratory health formulations. It is available in capsules, tablets, and softgels, often combined with other anti-inflammatory ingredients such as Curcumin, glucosamine, and chondroitin for synergistic effects.
The pharmaceutical industry utilizes standardized Boswellia Serrata Extract in medications for inflammatory conditions, including osteoarthritis, rheumatoid arthritis, and inflammatory bowel disease. The extract is also finding applications in topical formulations for localized pain relief.
For detailed product specifications and ordering information, visit www.greenskybio.com
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13
2026-07-13